Credit score: Pixabay/CC0 Public Area
Doctor–scientists on the College of Utah’s John A. Moran Eye Middle have revealed an investigatory overview of 9 sufferers who skilled imaginative and prescient problems whereas taking common semaglutide and tirzepatide medication prescribed for diabetes and weight reduction.
The researchers describe sufferers taking the medication who developed three doubtlessly blinding eye circumstances impacting the optic nerve, which carries visible info to the mind. Seven sufferers skilled nonarteritic anterior ischemic optic neuropathy (eye stroke), one had papillitis and one had paracentral acute center maculopathy.
This overview, coupled with the most recent analysis within the area, led the authors to hypothesize that speedy adjustments in blood sugar induced by these medication, moderately than a poisonous impact of the medication, might contribute to those problems.
The findings are revealed in JAMA Ophthalmology. Co-authors embrace researchers from the College of Minnesota, the State College of New York at Buffalo and West Virginia College Hospitals.
“This review was not conducted in any way that we can say these drugs caused the complications,” stated lead creator Bradley Katz, a professor within the U’s Division of Ophthalmology & Visible Sciences. “Further studies are needed to test our hypothesis. However, this is an important issue for ophthalmologists as we monitor the usage of these drugs and how to best be in communication with our patients about them.”
Semaglutide is the lively ingredient in Ozempic, Wegovy and Rybelsus, whereas tirzepatide is the lively ingredient in Mounjaro and Zepbound. Practically 2% of the U.S. inhabitants acquired a prescription for semaglutide in 2023.
A 2024 research instructed a potential connection between semaglutide use and elevated threat for eye stroke, prompting the American Academy of Ophthalmologists to alert physicians and sufferers. An ongoing five-year research is inspecting the impact of semaglutide on eye illness in folks with Kind 2 diabetes.
“Because of the association of semaglutide with a temporary worsening of diabetic retinopathy, the increased incidence of diabetic macular edema, and the concern that rapid correction of hyperglycemia could induce papillitis, physicians prescribing this medication to their patients with type two diabetes should consider a drug regimen that more gradually lowers HbA1C level,” wrote the authors.
Katz stated sufferers taking the medication below the care of their physician mustn’t cease taking them. Nonetheless, if they’ve a sudden lack of imaginative and prescient, they need to cease taking the drug and see a physician instantly.
Extra info:
Bradley J. Katz et al, Ophthalmic Problems Related With the Antidiabetic Medicine Semaglutide and Tirzepatide, JAMA Ophthalmology (2025). DOI: 10.1001/jamaophthalmol.2024.6058
Offered by
College of Utah
Quotation:
Researchers probe potential function of Ozempic, different weight-loss medication in imaginative and prescient loss (2025, February 4)
retrieved 4 February 2025
from https://medicalxpress.com/information/2025-02-probe-potential-role-ozempic-weight.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
